Dr. Michael Engelbert was featured on the Review of Ophthalmology en español cover for his work on the understanding of vitreous structure. To read the entire publication, click here.
VRMNY is recruiting patients for the BOULEVARD study, a Phase II clinical trial for newly diagnosed diabetic macular edema (DME). Patients will be randomized to receive standard anti-VEGF Lucentis injections or a new drug that combines anti-VEGF and anti-Ang2.
Ang2 is another factor that promotes new abnormal blood vessel formation. This 7-month study will help determine if this new combination drug better preserves the vision of patients with DME. Treatments will be provided free of charge.
For more information or to see if you qualify for the study, contact our research department at email@example.com or (212) 452-6965. You may also visit the BOULEVARD Clinical Trials website.
Congratulations to Dr. Richard Spaide, featured as one of New York Magazine’s 2016 Best Doctors.
Each year, New York Magazine works with Castle Connelly Medical Ltd. to publish a database of the best doctors in the New York City area.
Dr. Lawrence Yannuzzi was the recipient of Fight for Sight’s 2016 Weisenfeld Award at the Association for Research in Vision and Ophthalmology (ARVO) conference in Seattle last week. Dr. Yannuzzi received the award after lecturing on “The Legend of Central Serous Chorioretinopathy.”
Dr. K. Bailey Freund spoke on Multimodal Imaging in the Pachychoroid Spectrum at Pacific Retina Club’s International Retinal Imaging Symposium meeting last weekend. This information aids in diagnosing and treating central serous chorioretinopathy, pachychoroid vasculopathy, and choroidal neovascularization.
Join us for a night of education about diabetes and the eye! In conjunction with the American Diabetes Association-Greater New York, we are happy to announce a program featuring education lectures, free eye screenings, and refreshments.
Call (212) 861-9797 or email firstname.lastname@example.org for more info.